Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
21.22B | 21.00B | 18.10B | 19.42B | 18.81B | 19.54B | Gross Profit |
20.36B | 0.00 | 18.10B | 19.42B | 18.81B | 19.54B | EBIT |
6.95B | 4.57B | 6.47B | 1.19B | 2.05B | 1.59B | EBITDA |
2.77B | 4.57B | 3.26B | 2.53B | 3.57B | 3.12B | Net Income Common Stockholders |
2.08B | 2.50B | 1.72B | 1.28B | 2.04B | 1.57B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
141.09B | 0.00 | 85.98B | 104.37B | 237.74B | 231.90B | Total Assets |
1.71T | 1.68T | 1.63T | 1.61T | 1.70T | 1.71T | Total Debt |
117.54B | 116.85B | 94.47B | 52.10B | 138.00B | 117.34B | Net Debt |
-23.55B | 116.85B | -85.98B | -52.27B | -99.74B | -114.56B | Total Liabilities |
1.63T | 1.60T | 1.55T | 63.97B | 1.62T | 1.63T | Stockholders Equity |
75.91B | 74.98B | 77.65B | 73.11B | 76.98B | 79.23B |
Cash Flow | Free Cash Flow | ||||
0.00 | 13.54B | 10.89B | -139.63B | -4.52B | 142.68B | Operating Cash Flow |
0.00 | 14.19B | 1.60B | -139.40B | -4.19B | 143.44B | Investing Cash Flow |
0.00 | -21.80B | -19.40B | 6.62B | 10.63B | -1.67B | Financing Cash Flow |
0.00 | 48.74B | -592.00M | -589.00M | -592.00M | -736.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $921.10B | 12.37 | 6.30% | 3.41% | 9.28% | 20.48% | |
71 Outperform | ¥330.96B | 8.66 | 1.48% | 21.04% | 20.47% | ||
67 Neutral | $16.17B | 10.98 | 9.72% | 4.07% | 11.95% | -10.49% | |
62 Neutral | ¥13.26B | 5.36 | 4.99% | 8.63% | 17.45% | ||
52 Neutral | ¥44.89B | 10.57 | 3.77% | -16.07% | 43.79% |